Lipopolysaccharide	0	17
from	19	22
nonvirulent	24	34
Ara	36	38
+	39	39
Burkholderia	41	52
pseudomallei	54	65
isolates	67	74
is	76	77
immunologically	79	93
indistinguishable	95	111
from	113	116
lipopolysaccharide	118	135
from	137	140
virulent	142	149
Ara	151	153
-	154	154
clinical	156	163
isolates	165	172
.	173	173

Different	175	183
lines	185	189
of	191	192
evidence	194	201
suggest	203	209
that	211	214
a	216	216
discrepancy	218	228
between	230	236
the	238	240
distribution	242	253
of	255	256
Burkholderia	258	269
(	271	271
Pseudomonas	272	282
)	283	283
pseudomallei	285	296
in	298	299
the	301	303
environment	305	315
and	317	319
the	321	323
distribution	325	336
of	338	339
the	341	343
disease	345	351
melioidosis	353	363
is	365	366
attributable	368	379
,	380	380
at	382	383
least	385	389
in	391	392
part	394	397
,	398	398
to	400	401
phenotypic	403	412
differences	414	424
between	426	432
clinical	434	441
and	443	445
some	447	450
environmental	452	464
isolates	466	473
.	474	474

Two	476	478
antigenically	480	492
and	494	496
biochemically	498	510
distinct	512	519
biotypes	521	528
have	530	533
been	535	538
described	540	548
,	549	549
only	551	554
one	556	558
of	560	561
which	563	567
is	569	570
virulent	572	579
.	580	580

In	582	583
this	585	588
study	590	594
,	595	595
lipopolysaccharides	597	615
(	617	617
LPSs	618	621
)	622	622
were	624	627
extracted	629	637
by	639	640
the	642	644
proteinase	646	655
K	657	657
digestion	659	667
method	669	674
from	676	679
a	681	681
total	683	687
of	689	690
214	692	694
B	696	696
.	697	697
pseudomallei	699	710
isolates	712	719
,	720	720
and	722	724
their	726	730
immunoreactivities	732	749
with	751	754
sera	756	759
from	761	764
patients	766	773
with	775	778
different	780	788
clinical	790	797
spectra	799	805
and	807	809
with	811	814
other	816	820
infections	822	831
were	833	836
evaluated	838	846
.	847	847

With	849	852
the	854	856
exception	858	866
of4	868	870
isolates	872	879
from	881	884
a	886	886
total	888	892
of	894	895
214	897	899
tested	901	906
,	907	907
the	909	911
sodium	913	918
dodecyl	920	926
sulfate	928	934
-	935	935
polyacrylamide	936	949
gel	951	953
electrophoresis	955	969
silver	971	976
-	977	977
staining	978	985
profiles	987	994
of	996	997
the	999	1001
LPSs	1003	1006
from	1008	1011
the	1013	1015
two	1017	1019
biotypes	1021	1028
showed	1030	1035
identical	1037	1045
ladder	1047	1052
patterns	1054	1061
that	1063	1066
were	1068	1071
typical	1073	1079
for	1081	1083
smooth	1085	1090
LPSs	1092	1095
from	1097	1100
other	1102	1106
gram	1108	1111
-	1112	1112
negative	1113	1120
bacteria	1122	1129
.	1130	1130

The	1132	1134
210	1136	1138
isolates	1140	1147
with	1149	1152
typical	1154	1160
LPS	1162	1164
patterns	1166	1173
(	1175	1175
119	1176	1178
Ara	1180	1182
-	1183	1183
clinical	1185	1192
,	1193	1193
13	1195	1196
Ara	1198	1200
-	1201	1201
soil	1203	1206
,	1207	1207
70	1209	1210
Ara	1212	1214
+	1215	1215
soil	1217	1220
,	1221	1221
and	1223	1225
8	1227	1227
reference	1229	1237
National	1239	1246
Type	1248	1251
Culture	1253	1259
Collection	1261	1270
strains	1272	1278
)	1279	1279
also	1281	1284
exhibited	1286	1294
similar	1296	1302
immunoblot	1304	1313
profiles	1315	1322
against	1324	1330
pooled	1332	1337
sera	1339	1342
from	1344	1347
patients	1349	1356
with	1358	1361
melioidosis	1363	1373
and	1375	1377
hyperimmune	1379	1389
mouse	1391	1395
sera	1397	1400
.	1401	1401

Concordant	1403	1412
findings	1414	1421
were	1423	1426
noted	1428	1432
in	1434	1435
the	1437	1439
indirect	1441	1448
enzyme	1450	1455
-	1456	1456
linked	1457	1462
immunosorbent	1464	1476
assay	1478	1482
with	1484	1487
Ara	1489	1491
-	1492	1492
and	1494	1496
Ara	1498	1500
+	1501	1501
LPSs	1503	1506
to	1508	1509
coat	1511	1514
the	1516	1518
microtiter	1520	1529
plates	1531	1536
.	1537	1537

The	1539	1541
LPSs	1543	1546
of	1548	1549
the	1551	1553
different	1555	1563
B	1565	1565
.	1566	1566
pseudomallei	1568	1579
biotypes	1581	1588
appear	1590	1595
antigenically	1597	1609
indistinguishable	1611	1627
.	1628	1628

It	1630	1631
is	1633	1634
,	1635	1635
therefore	1637	1645
,	1646	1646
unlikely	1648	1655
that	1657	1660
this	1662	1665
component	1667	1675
is	1677	1678
related	1680	1686
to	1688	1689
the	1691	1693
virulence	1695	1703
and	1705	1707
pathogenicity	1709	1721
of	1723	1724
B	1726	1726
.	1727	1727
pseudomallei	1729	1740
.	1741	1741
